# Early Caffeine in Preterm Neonates

> **NCT03086473** · PHASE4 · UNKNOWN · sponsor: **Jennifer Shepherd** · enrollment: 24 (actual)

## Conditions studied

- BPD - Bronchopulmonary Dysplasia
- Apnea of Prematurity
- Hemodynamic Instability
- Intubation

## Interventions

- **DRUG:** Caffeine Citrate
- **DRUG:** Placebo (Normal Saline)

## Key facts

- **NCT ID:** NCT03086473
- **Lead sponsor:** Jennifer Shepherd
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-01
- **Primary completion:** 2022-01
- **Final completion:** 2022-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03086473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03086473, "Early Caffeine in Preterm Neonates". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03086473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*